Understanding Lab Tests for Ovarian Cancer
Written by Private MD Labs Medical Writing Team • Last Updated: September 8, 2025
Ovarian cancer is a serious malignancy that primarily requires imaging studies and tissue biopsy for definitive diagnosis. While there is no single blood test that can definitively diagnose ovarian cancer, certain tumor markers and biomarkers play a crucial role in monitoring, assessing treatment response, and evaluating risk in combination with other diagnostic methods.
Top Recommended Test
CA-125 (Ovarian Cancer Test)
CA-125 is the most commonly used biomarker for ovarian cancer. High levels are often found in patients with ovarian cancer and can be valuable for monitoring treatment response and detecting recurrence. However, elevated levels can also occur in other conditions, so this test is not definitive for diagnosis but serves as an important monitoring tool when ovarian cancer is suspected or confirmed.
2907 reviews
The Role of Blood Testing in Ovarian Cancer
Blood tests measuring cancer antigens (tumor markers) are fundamental tools for healthcare providers to monitor patients with known ovarian cancer, assess treatment effectiveness, detect potential recurrence, and sometimes help evaluate suspicious symptoms. These markers can provide valuable information about the body's response to cancer, though they must always be interpreted alongside clinical findings and imaging results.
Other Relevant Tests
Carbohydrate Antigen (CA) 19-9
While CA 19-9 is not specific to ovarian cancer, elevated levels can occasionally indicate its presence, particularly when used alongside other biomarkers like CA-125. In rare cases, this marker may be elevated in ovarian cancer patients and can provide additional information when used as part of a comprehensive biomarker panel.
2907 reviews
Cancer Antigen (CA) 15-3
Although CA 15-3 is primarily associated with breast cancer, it can also be elevated in other malignancies including ovarian cancer. While not routinely used as a primary diagnostic or monitoring tool for ovarian cancer, it may provide supplementary information in certain clinical situations.
2907 reviews
CA 27.29
CA 27.29 can occasionally be elevated in ovarian cancer, though it is not commonly used as a primary diagnostic tool due to its low specificity for this type of cancer. It may serve as an additional biomarker in comprehensive cancer monitoring panels when clinically appropriate.
2907 reviews
Understanding Test Limitations
It's important to understand that elevated cancer antigen levels can occur in benign conditions, other types of cancer, and even in healthy individuals. These tests are most valuable when used in conjunction with clinical evaluation, imaging studies, and other diagnostic methods by qualified healthcare professionals.
Important Considerations
The information here is for educational purposes only and is not a substitute for professional medical advice. Always consult with a healthcare provider for diagnosis and treatment. Cancer biomarker tests should only be interpreted by qualified medical professionals in the context of your complete medical history and clinical presentation.
